For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ciclosporin 0.1% Eye Drops (Verkazia) - Allergic conjunctivitis
PAD Profile : Ciclosporin 0.1% Eye Drops (Verkazia) - Allergic conjunctivitis
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Sodium cromoglicate
- Antazoline
- Azelastine hydrochloride
- Ketotifen fumarate
- Lodoxamide trometamol
- Olopatadine
Other Indications
- Dermatology indications
- Psoriatic arthritis
- Inflammatory bowel disease
- Dry eyes
- Dry eyes
- Neurology indications
- Uveitis
- Renal indications
- Rheumatology indications
- Ocular surface disease
Additional Documents
No additional documents returned.
Committee Recommendations
This drug has not yet been evaluated by the Surrey and Sussex Prescribing Clinical Network (PCN). As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.
This drug is currently not on the PCN workplan. The PCN will consider recommending prescribing of this treatment upon submission of a formal request with its associated evidence. Please contact your local CCG Medicines Management team formulary pharmacist or chief pharmacist at your acute trust, if you wish to make a submission.
If asked to prescribe, please contact a member of your Medicines Management Team